Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Berg

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
European Journal of Human Genetics : EJHG|November 6, 2009
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effectsVinciane Wouters, Nisha Limaye, Melanie Uebelhoer, et al.
Iscience|December 5, 2022
PERIOD 2 regulates low-dose radioprotection via PER2/pGSK3β/β-catenin/Per2 loopAris T Alexandrou, Yixin Duan, Shanxiu Xu, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
European Journal of Human Genetics : EJHG|December 6, 2022
Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testingLynne J Hocking, Claire Andrews, Christine Armstrong, et al.
Breast Cancer Research and Treatment|July 9, 2014
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastasesCarey Anders, Allison M Deal, Vandana Abramson, et al.
Familial Cancer|June 19, 2008
Predicting breast cancer risk: implications of a "weak" family historyElaine Anderson, Jonathan Berg, Roger Black, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2026
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trialJohn Burn, Gillian M Borthwick, Faye Elliott, et al.
Human Molecular Genetics|November 11, 2011
Gene-gene interactions in breast cancer susceptibilityClare Turnbull, Sheila Seal, Anthony Renwick, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the Clinical Validity of 111 Gene-Disease RelationshipsEleanor Broeren, Vanessa Gitau, Alicia Byrne, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
European Journal of Human Genetics : EJHG|November 6, 2009
Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effectsVinciane Wouters, Nisha Limaye, Melanie Uebelhoer, et al.
Iscience|December 5, 2022
PERIOD 2 regulates low-dose radioprotection via PER2/pGSK3β/β-catenin/Per2 loopAris T Alexandrou, Yixin Duan, Shanxiu Xu, et al.
Pharmacogenetics and Genomics|February 15, 2013
Nomenclature for alleles of the thiopurine methyltransferase geneMalin L Appell, Jonathan Berg, John Duley, et al.
European Journal of Human Genetics : EJHG|December 6, 2022
Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testingLynne J Hocking, Claire Andrews, Christine Armstrong, et al.
Breast Cancer Research and Treatment|July 9, 2014
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastasesCarey Anders, Allison M Deal, Vandana Abramson, et al.
Familial Cancer|June 19, 2008
Predicting breast cancer risk: implications of a "weak" family historyElaine Anderson, Jonathan Berg, Roger Black, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2026
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trialJohn Burn, Gillian M Borthwick, Faye Elliott, et al.
Human Molecular Genetics|November 11, 2011
Gene-gene interactions in breast cancer susceptibilityClare Turnbull, Sheila Seal, Anthony Renwick, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
The ClinGen Syndromic Disorders Gene Curation Expert Panel: Assessing the Clinical Validity of 111 Gene-Disease RelationshipsEleanor Broeren, Vanessa Gitau, Alicia Byrne, et al.
Pageof 8